Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
Journal: Journal of neuro-oncology
Published: March 22, 2026
A multimodal MRI-radiomics deep learning model for survival risk stratification after gamma knife radiosurgery in patients with brain metastases: A multicenter retrospective study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 18, 2026
Correction: Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function.
Journal: The Journal of experimental medicine
Published: February 05, 2026
User-centered design of a COPD care pathway for patients with cancer: a mixed-methods clinical trial protocol.
Journal: Future oncology (London, England)
Published: October 14, 2025
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313).
Journal: The oncologist
Published: July 09, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
Journal: Cancers
Published: February 06, 2025
Survival impact of immune-related adverse events in extensive stage small cell lung cancer patients: a retrospective cohort study.
Journal: Immunotherapy
Published: January 23, 2025
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 23, 2025
Retraction Note: Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
Journal: Oncogene
Published: January 09, 2025
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening.
Journal: Neoplasia (New York, N.Y.)
Published: October 23, 2024
External validation of a genomic signature for oligometastatic non-small cell lung cancer.
Journal: Journal of radiosurgery and SBRT
Published: October 14, 2024
Last Updated: 09/26/2026